HBIO vs HSTM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

HBIO

38.9
AI Score
VS
HBIO Wins

HSTM

38.8
AI Score

Investment Advisor Scores

HBIO

39score
Recommendation
AVOID NEW MONEY

HSTM

39score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric HBIO HSTM Winner
Forward P/E 15.0602 36.63 HBIO
PEG Ratio 1.3059 3.0475 HBIO
Revenue Growth 11.1% 8.9% HBIO
Earnings Growth -80.3% -10.0% HSTM
Tradestie Score 38.9/100 38.8/100 HBIO
Profit Margin -11.9% 6.2% HSTM
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

HBIO 1M: +20.4% · 3M: +49.3% HSTM 1M: -14.3% · 3M: -0.3%

Current Technical Phase

HBIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.9% over 20 days), RSI 75

RSI (14): 75.5 · Price: $9.96

HSTM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 34

RSI (14): 33.9 · Price: $28.93

Fundamentals Snapshot

Metric HBIO HSTM
Market Cap — —
Forward P/E 14.4 31.2
Trailing P/E — 41.2
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.6% 0.6%
Operating Margin 0.0% 0.1%
EPS -2.31 0.70
Dividend Yield — 0.00%

Frequently Asked Questions

Based on our detailed analysis, HBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.